Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

The Revised Human Liver Cytochrome P450 “Pie”: Absolute Protein Quantification of CYP4F and CYP3A Enzymes Using Targeted Quantitative Proteomics

Scott Michaels and Michael Zhuo Wang
Drug Metabolism and Disposition August 2014, 42 (8) 1241-1251; DOI: https://doi.org/10.1124/dmd.114.058040
Scott Michaels
Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas (M.Z.W., S.M.); Wolfe Laboratories, Inc., Watertown, Massachusetts (S.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Zhuo Wang
Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas (M.Z.W., S.M.); Wolfe Laboratories, Inc., Watertown, Massachusetts (S.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 42 no. 8 1241-1251
DOI 
https://doi.org/10.1124/dmd.114.058040
PubMed 
24816681

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received March 11, 2014
  • Accepted May 9, 2014
  • Published online June 25, 2014.

Article Versions

  • Earlier version (May 9, 2014 - 08:39).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Scott Michaels and
  2. Michael Zhuo Wang
  1. Department of Pharmaceutical Chemistry, School of Pharmacy, University of Kansas, Lawrence, Kansas (M.Z.W., S.M.); Wolfe Laboratories, Inc., Watertown, Massachusetts (S.M.)
  1. Address correspondence to:
    Dr. Michael Zhuo Wang, 2095 Constant Avenue, University of Kansas, Lawrence, KS 66047. E-mail: michael.wang{at}ku.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to August 2022

AbstractFullPdf
Aug 201733426
Sep 201712213
Oct 201723819
Nov 201732811
Dec 201751913
Jan 20181269
Feb 20184329
Mar 201813824
Apr 201814219
May 201862930
Jun 201832120
Jul 201832814
Aug 201813114
Sep 201812610
Oct 201861417
Nov 20181135
Dec 201821815
Jan 20195318
Feb 201991216
Mar 201963718
Apr 201972022
May 201912811
Jun 201922013
Jul 20193043
Aug 201931710
Oct 2019281111
Nov 20193132
Dec 2019142716
Jan 202052513
Feb 202042820
Mar 20205216
May 202014417
Jun 20205196
Jul 20203000
Aug 20202347
Sep 20201331
Oct 20205221
Nov 20202944
Dec 20202597
Jan 202136166
Feb 202120205
Mar 20212361
Apr 20212142
May 20211882
Jun 20211581
Jul 20212273
Aug 202121113
Sep 202113128
Oct 20211869
Nov 20212185
Dec 20212733
Jan 202236117
Feb 20222576
Mar 202227128
Apr 2022281013
May 20221330
Jun 20223141
Jul 202240316
Aug 20221611

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 42 (8)
Drug Metabolism and Disposition
Vol. 42, Issue 8
1 Aug 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Revised Human Liver Cytochrome P450 “Pie”: Absolute Protein Quantification of CYP4F and CYP3A Enzymes Using Targeted Quantitative Proteomics
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

CYP4F and Revised Human Liver P450 “Pie”

Scott Michaels and Michael Zhuo Wang
Drug Metabolism and Disposition August 1, 2014, 42 (8) 1241-1251; DOI: https://doi.org/10.1124/dmd.114.058040

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

CYP4F and Revised Human Liver P450 “Pie”

Scott Michaels and Michael Zhuo Wang
Drug Metabolism and Disposition August 1, 2014, 42 (8) 1241-1251; DOI: https://doi.org/10.1124/dmd.114.058040
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Human ADME Properties of Abrocitinib
  • MSCs Pharmacokinetics under liver diseases
  • In Vitro P450 Suppression by Peptide Not Observed in Clinic
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics